SecSonar.com

McKesson Corporation (MCK)

McKesson Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

McKesson Corporation (MCK) is a Medical - Distribution company based in US with a market capitalization of $89.3B. Revenue grew 12.4% year-over-year and the company generated $5.7B in free cash flow. This page tracks MCK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 44K employees · IPO Nov 10, 1994

Valuation

Valuation & price

$760.57 · as of May 17, 2026 · -23.6% vs 52w high

19.8

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$991$827$663Jul 25Dec 25Jul 26Jul 7, 25$735.33Jul 9, 25$727.23Jul 11, 25$709.59Jul 15, 25$710.82Jul 17, 25$710.28Jul 21, 25$711.21Jul 23, 25$714.00Jul 25, 25$711.82Jul 29, 25$712.15Jul 31, 25$693.54Aug 4, 25$710.94Aug 6, 25$703.76Aug 11, 25$672.77Aug 13, 25$663.17Aug 15, 25$673.05Aug 19, 25$676.91Aug 21, 25$706.00Aug 25, 25$678.91Aug 27, 25$683.51Aug 29, 25$686.64Sep 3, 25$690.84Sep 5, 25$687.40Sep 9, 25$705.55Sep 11, 25$719.80Sep 16, 25$693.45Sep 18, 25$690.13Sep 22, 25$697.00Sep 24, 25$760.58Sep 26, 25$760.55Sep 30, 25$772.54Oct 2, 25$758.70Oct 6, 25$741.29Oct 8, 25$755.75Oct 10, 25$763.55Oct 14, 25$781.90Oct 16, 25$775.44Oct 21, 25$787.29Oct 23, 25$792.97Oct 27, 25$811.44Oct 29, 25$807.63Oct 31, 25$811.34Nov 4, 25$841.67Nov 6, 25$858.61Nov 10, 25$859.37Nov 12, 25$840.75Nov 14, 25$842.09Nov 18, 25$860.75Nov 20, 25$849.46Nov 25, 25$889.28Nov 28, 25$881.12Dec 2, 25$829.70Dec 4, 25$814.18Dec 8, 25$797.93Dec 10, 25$813.10Dec 12, 25$813.80Dec 16, 25$809.96Dec 18, 25$810.56Dec 22, 25$818.40Dec 24, 25$826.43Dec 29, 25$830.42Jan 2, 26$823.44Jan 6, 26$826.51Jan 8, 26$814.63Jan 12, 26$825.62Jan 14, 26$834.16Jan 16, 26$840.46Jan 21, 26$823.25Jan 23, 26$820.23Jan 27, 26$834.18Jan 29, 26$822.30Feb 2, 26$846.51Feb 4, 26$822.00Feb 9, 26$962.32Feb 11, 26$953.19Feb 13, 26$934.75Feb 18, 26$946.97Feb 20, 26$947.48Feb 24, 26$957.36Feb 26, 26$974.45Mar 2, 26$990.95Mar 4, 26$978.71Mar 6, 26$919.26Mar 10, 26$928.69Mar 12, 26$944.36Mar 17, 26$941.89Mar 19, 26$898.95Mar 23, 26$877.01Mar 25, 26$879.75Mar 27, 26$860.16Mar 31, 26$865.36Apr 2, 26$884.28Apr 7, 26$856.62Apr 9, 26$873.43Apr 13, 26$864.57Apr 15, 26$863.42Apr 17, 26$866.38Apr 22, 26$829.23Apr 24, 26$828.11Apr 28, 26$835.00Apr 30, 26$815.20May 4, 26$807.85May 6, 26$743.67May 8, 26$736.09May 12, 26$734.69May 14, 26$747.23May 18, 26$775.97May 20, 26$754.68May 22, 26$766.08May 28, 26$756.98Jun 1, 26$734.82Jun 3, 26$739.53Jun 5, 26$775.66Jun 9, 26$784.23Jun 11, 26$787.19Jun 15, 26$779.78Jun 17, 26$779.80Jun 22, 26$744.85Jun 24, 26$766.55Jun 26, 26$763.51Jul 2, 26$786.30
$659.0152-week range$995.69
Loading valuation history…

Fundamentals

Key fundamentals

$89.3B

Market cap

12.4%

Revenue growth (YoY)

3.6%

Gross margin

$5.7B

Free cash flow (USD)

$4.6B

Net debt

-3.0%

Share dilution

2/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2026

FY 2017$198.5BFY 2018$208.4BFY 2019$214.3BFY 2020$231.1BFY 2021$238.2BFY 2022$264.0BFY 2023$276.7BFY 2024$309.0BFY 2025$359.1BFY 2026$403.4B
$198.5B$403.4B

Free cash flow by year

2017 → 2026

FY 2017$4.2BFY 2018$3.8BFY 2019$3.5BFY 2020$3.9BFY 2021$3.9BFY 2022$3.9BFY 2023$4.6BFY 2024$3.6BFY 2025$5.2BFY 2026$5.7B
$4.2B$5.7B

Gross margin by year

2022 → 2026

FY 20224.8%FY 20234.3%FY 20244.0%FY 20253.5%FY 20263.6%
4.8%3.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last report: 10-K filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventExecutive RetirementJul 1, 2026Filing
  • Insider sellInsider Sell $6.6M · 10b5-1 PlanTYLER BRIAN S. · Director, Chief Executive Officer · $6.6MJun 18, 2026Filing
  • 8-K eventDebt RefinancingJun 12, 2026Filing
  • Insider sellInsider Sell $3.8M · 10b5-1 PlanTYLER BRIAN S. · Director, Chief Executive Officer · $3.8MJun 11, 2026Filing
  • Insider sellInsider Sell $102K · 10b5-1 PlanRutledge Napoleon B JR · SVP, Controller & CAO · $101.6KJun 8, 2026Filing
  • Insider sellInsider Sell $604K · 10b5-1 PlanRodgers Thomas L · EVP, Chief Strategy & BDO · $604.4KJun 3, 2026Filing
  • Insider sellInsider Sell $1.3M · 10b5-1 PlanSmith LeAnn B · EVP & Chief HR Officer · $1.3MJun 2, 2026Filing
  • Insider sellInsider Sell $1.8M · 10b5-1 PlanRodgers Thomas L · EVP, Chief Strategy & BDO · $1.8MMay 27, 2026Filing
  • Insider sellInsider Sell $2.7M · 10b5-1 PlanLau Michele · EVP and Chief Legal Officer · $2.7MMay 27, 2026Filing
  • Annual report10-K FiledMay 8, 2026Filing

Questions

Frequently asked questions

What is McKesson Corporation's market cap?

McKesson Corporation (MCK) has a market capitalization of $89.3B.

What is MCK's P/E ratio?

MCK trades at a price-to-earnings ratio of 19.8, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

Are insiders buying MCK stock?

SEC Form 4 filings show no open-market insider buys at McKesson Corporation in the last 90 days (7 sells).

Same arena

Related companies in Medical - Distribution

COR

Cencora, Inc.

$52B

CAH

Cardinal Health, Inc.

$46.2B

HSIC

Henry Schein, Inc.

$8.8B

GRDN

Guardian Pharmacy Services, Inc.

$2.4B

PBH

Prestige Consumer Healthcare Inc.

$2.3B

ACH

Accendra Health, Inc.

$219.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.